Analytical Data
-
基因名
TINAGL1
- Application
-
别名
ARG1; LCN7; LIECG3; AZ-1; TINAGRP; GIS5; OLRG2; TINAGL; Lipocalin 7; Adrenocortical Zonation Factor 1; Glucocorticoid-inducible protein 5; Oxidized LDL-responsive gene 2
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
Q9GZM7
-
表达区间
Val81~His467
-
分子量
47kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TINAGL1 (Tina G-like protein 1) is a recently identified protein that plays a significant role in various physiological processes, including cellular interactions and signaling pathways. Research has shown that TINAGL1 is involved in cell adhesion and the regulation of extracellular matrix components, which are crucial for tissue development and maintenance. Its expression has been linked to several diseases, including tumors and fibrosis, suggesting that it may serve as a potential biomarker for disease progression. The recombinant production of TINAGL1 has gained interest among researchers aiming to elucidate its structure-function relationships and understand its biological significance. Using recombinant DNA technology, scientists can produce large quantities of TINAGL1 for in vitro studies, allowing for the investigation of its interactions with other proteins and its role in pathological conditions. By studying TINAGL1, researchers hope to uncover new therapeutic targets and strategies for treating diseases associated with dysregulated cell-matrix interactions. Understanding TINAGL1's molecular mechanisms can offer insights into its potential utility in regenerative medicine, cancer therapy, and tissue engineering, making it a compelling focus for ongoing biomedical research.
